Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections

This study has been completed.
Sponsor:
Collaborator:
American Academy of Family Physicians National Research Network
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT00996112
First received: October 15, 2009
Last updated: January 23, 2013
Last verified: November 2010
  Purpose

The goal of this study is to further the investigators' understanding of community acquired methicillin-resistant Staph Aureus (CA-MRSA) and treatment of it by developing real-world sustainable strategies consistent with existing guidelines on treatment of CA-MRSA from the Centers for Disease Control and Prevention (CDC) and test these strategies in busy primary care settings.


Condition
Methicillin-Resistant Staphylococcus Aureus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Management by Primary Care Clinicians of Patients Suspected of Having Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections

Resource links provided by NLM:


Further study details as provided by University of Colorado, Denver:

Primary Outcome Measures:
  • Physician Behavior Change [ Time Frame: Throughout study participation ] [ Designated as safety issue: Yes ]
    Intervention in practice for guideline-concordant care of CA MRSA


Enrollment: 4518
Study Start Date: October 2009
Study Completion Date: August 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Historical
Prospective

  Eligibility

Ages Eligible for Study:   up to 89 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The study population comprises primary care patients in ambulatory clinics from two health care systems.

Criteria

Inclusion Criteria:

  • All patients presenting at a primary care clinic who have a skin or soft tissue infection.

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00996112

Locations
United States, Colorado
University of Colorado Denver
Aurora, Colorado, United States, 80045
Sponsors and Collaborators
University of Colorado, Denver
American Academy of Family Physicians National Research Network
Investigators
Principal Investigator: David R West, PhD Department of Family Medicine, University of Colorado Denver
  More Information

No publications provided

Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT00996112     History of Changes
Other Study ID Numbers: 09-0265, AHRQ 04-109-6314
Study First Received: October 15, 2009
Last Updated: January 23, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Colorado, Denver:
primary health care

Additional relevant MeSH terms:
Staphylococcal Infections
Bacterial Infections
Gram-Positive Bacterial Infections

ClinicalTrials.gov processed this record on October 29, 2014